top of page

Sequencing effort aims to improve drug-resistant TB diagnosis, treatment

A massive new analysis of Mycobacterium tuberculosis isolates from around the world provides an "unparalleled view" of the mechanisms behind drug-resistant tuberculosis (TB). The analysis, described in two studies published last week in PLOS Biology, was conducted by scientists working with CRyPTIC (Comprehensive Resistance Prediction for Tuberculosis: an International Consortium), a large international effort employing whole-genome sequence (WGS) to create a comprehensive map of the genetic changes that are responsible for making TB drug-resistant. Read more here.


25 views0 comments

Recent Posts

See All

Treat Action Group 2023 Pipeline Report

Their annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB). View the full

Comments


bottom of page